The UK CBD Market was valued at USD 893.75 Million in 2024 and is projected to reach USD 2,399.90 Million by 2033, growing at a CAGR of 11.60% during the forecast period 2025-2033. Market growth is driven by ongoing product legalization, rising health and wellness trends, expansion of product offerings, e-commerce growth, and enhanced consumer education in the UK.
Study Assumption Years
Base Year: 2024
Historical Year/Period: 2019-2024
Forecast Year/Period: 2025-2033
UK CBD Market Key Takeaways
The UK CBD market size was USD 893.75 Million in 2024.
The market is expected to exhibit a CAGR of 11.60% from 2025 to 2033.
Forecast period for the market is 2025-2033.
Legalization and regulation of CBD products foster consumer trust and ensure safety standards.
Health and wellness trends boost demand, with increasing use for anxiety, inflammation, and sleep management.
The diverse range of CBD products such as oils, gummies, beverages, skincare, and pet care appeal to varied consumer segments.
E-commerce growth and rising consumer education are key drivers supporting market expansion.
Sample Request Link: https://www.imarcgroup.com/uk-cbd-market/requestsample
Market Growth Factors
Legalization of the cannabidiol (CBD) product market in the UK is a key market driver for the industry. Legalization and regulation is expected to institutionalize the market, ensuring quality and safety, while reputable manufacturers increase consumer confidence through providing clear information on the source, formulation and testing of products. In December 2024, the UK's Food Standards Agency (FSA) announced the start of an eight-week consultation period (expected in early 2025) which would set the stage for the first approved CBD products to reach shelves in Spring/Summer 2025, following a positive safety assessment designed to restore consumer confidence and strengthen the industry.
Trends for health and wellness have driven the UK's demand for CBD products, with consumers seeking the perceived health benefits of CBD which may include anxiety relief, anti-inflammatory, and sleep-improvement. This follows a general trend of a preference towards natural and preventative healthcare as opposed to pharmaceutical drugs. In the UK, there has been market growth due to health conscious consumers adopting CBD products, partially eased by information and research available on the internet. Two NHS clinical trials will start in 2025 to assess the risks and benefits of CBD and THC for treatment-resistant epilepsy in 500 people.
This product expansion has helped the industry expand in terms of variety and consumer needs. In addition to the variety of products widely available on the UK market, products increasingly range from oils and tinctures to gummies, drinks, cosmetics and pet care. Given that these wide-range products appeal to consumers discouraged by raw forms of CBD, are being normalized in daily use, and are seeing new levels of product variation designed for specific needs like sleep, and stress relief, the overall outlook for the market remains positive. E-commerce growth and increasing consumer knowledge are also expected to support growth.
Market Segmentation
Source Insights:
Hemp-Based
Marijuana-Based
The market segmentation covers two primary sources of CBD, addressing diverse consumer needs by including both hemp-based and marijuana-based products.
Form Insights:
Processed Oil
Distillates
Isolates
The UK market offers CBD in multiple forms such as processed oils, distillates, and isolates, catering to different consumption preferences.
Grade Insights:
Food Grade
Therapeutic Grade
The report distinguishes between food-grade and therapeutic-grade CBD, addressing various applications and consumer requirements.
Application Insights:
Food and Beverages
Cosmetics and Personal Care
Pharmaceuticals
CBD products in the UK find wide application in food and beverages, cosmetics and personal care, and pharmaceutical sectors.
Distribution Channel Insights:
Offline
Online
The UK CBD market is served through both offline retail outlets and growing online e-commerce platforms.
Regional Insights
The UK CBD market includes key regional markets such as London, South East, North West, East of England, South West, Scotland, West Midlands, Yorkshire and The Humber, East Midlands, and others. These regions collectively contribute to the comprehensive market landscape, with London and South East typically recognized as dominant areas due to significant consumer base and retail infrastructure.
Recent Developments & News
In August 2024, Skip launched the UK’s first CBD-compliant drink containing 5mg of cold-pressed active CBD per 250 ml, with up to eight times the strength of standard CBD isolate. In October 2023, Holland & Barrett updated its UK-based CBD Trip to comply with the latest Food Standards Agency (FSA) regulations, which reduced the recommended daily CBD consumption from 70 mg to 10 mg.
Key Players
Skip
Holland & Barrett
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
